FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine, namely to infectious diseases, and is intended for the prevention of new coronavirus infection COVID-19. To prevent new coronavirus infection COVID-19, the method of administration of the sodium salt of 2-methylthio-6-nitro-1,2-4-triazol[5,1-c]-1,2,4-triazin-7-one, dihydrate, with antiviral activity is used. One capsule of the drug riamilovir is taken containing sodium salt of 2-methylthio-6-nitro-1,2-4-triazol[5,1-c]-1,2,4-triazin-7-one, dihydrate, in the dosage of 250 mg daily for 20 days.
EFFECT: invention ensures effective prevention of the development of new coronavirus infection COVID-19.
1 cl, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
APPLICATION OF METHOD FOR ADMINISTRATION OF SODIUM SALT OF 2-METHYLTHIO-6-NITRO-1,2-4-TRIAZOL[5,1-C] -1,2,4-TRIAZIN-7-ONE, DIHYDRATE WITH ANTIVIRAL ACTIVITY, FOR TREATMENT OF CORONAVIRUS INFECTION COVID-19 | 2021 |
|
RU2754532C1 |
USE OF METHOD FOR ADMINISTRATION OF SODIUM SALT OF 2-METHYLTHIO-6-NITRO-1,2-4-TRIAZOLO[5,1-c]-1,2,4-TRIAZINE-7-ONE, DIHYDRATE, HAVING ANTIVIRAL ACTIVITY FOR TREATMENT OF CORONAVIRUS INFECTION COVID-19 | 2020 |
|
RU2774860C2 |
ENCAPSULATED ANTIVIRAL MEDICATION AND ITS PRODUCTION METHOD | 2011 |
|
RU2451514C1 |
2-METHYLSULPHANYL-6-NITRO-OXO-1,2,4-TRIAZOLO[5,1-c] [1,2,4]TRIAZINIDE L-ARGININIUM DIHYDRATE, POSSESSING ANTIVIRAL ACTIVITY, METHOD OF ITS OBTAINING AND APPLICATION FOR PREVENTION AND TREATMENT OF WEST NILE FEVER | 2013 |
|
RU2536874C1 |
METHOD FOR PRODUCING 2-METHYLTHIO-6-NITRO-1,2-4-TRIAZOLO[5,1-C]-1,2,4-TRIAZIN-7-ONE SODIUM SALT DIHYDRATE POSESSING ANTIVIRAL ACTIVITY | 2020 |
|
RU2741502C1 |
TABLETTED ANTIVIRAL AGENT AND METHOD FOR PREPARING IT | 2010 |
|
RU2446802C2 |
ANTIVIRAL MEDICATION AND METHOD OF PREVENTION AND TREATMENT OF VIRAL INFECTIONS | 2010 |
|
RU2457844C2 |
ANTIVIRAL AGENT FOR PREVENTING AND TREATING TICK-BORNE ENCEPHALITIS | 2010 |
|
RU2444363C2 |
2-METHYLTHIO-6-NITRO-1,2,4-TRIAZOLO[5,1-C]-1,2,4-TRIAZINE-7(4H)-ONE SODIUM SALT DIHYDRATE POSSESSING ANTIVIRAL ACTIVITY | 2005 |
|
RU2294936C1 |
3-BENZYL-5-METHYL-6-(PHENYLTHIO)-[1,2,4]TRIAZOLO[1,5-a]PYRIMIDIN-7(3H)-ONE, WHICH HAS ANTIVIRAL ACTIVITY AGAINST THE SARS-CoV2 CORONAVIRUS | 2022 |
|
RU2808622C1 |
Authors
Dates
2021-09-03—Published
2021-03-24—Filed